These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 3098417

  • 1. Phase I study of i.v. administered recombinant gamma interferon in cancer patients.
    Kurzrock R, Quesada JR, Rosenblum MG, Sherwin SA, Gutterman JU.
    Cancer Treat Rep; 1986 Dec; 70(12):1357-64. PubMed ID: 3098417
    [Abstract] [Full Text] [Related]

  • 2. Phase I trial of recombinant interferon gamma by 1-hour i.v. infusion.
    Vadhan-Raj S, Nathan CF, Sherwin SA, Oettgen HF, Krown SE.
    Cancer Treat Rep; 1986 May; 70(5):609-14. PubMed ID: 3085930
    [Abstract] [Full Text] [Related]

  • 3. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.
    Weiner LM, Li W, Holmes M, Catalano RB, Dovnarsky M, Padavic K, Alpaugh RK.
    Cancer Res; 1994 Aug 01; 54(15):4084-90. PubMed ID: 8033141
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Phase II studies of recombinant human interferon gamma in metastatic renal cell carcinoma.
    Quesada JR, Kurzrock R, Sherwin SA, Gutterman JU.
    J Biol Response Mod; 1987 Feb 01; 6(1):20-7. PubMed ID: 3104544
    [Abstract] [Full Text] [Related]

  • 10. Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.
    Atkins MB, Robertson MJ, Gordon M, Lotze MT, DeCoste M, DuBois JS, Ritz J, Sandler AB, Edington HD, Garzone PD, Mier JW, Canning CM, Battiato L, Tahara H, Sherman ML.
    Clin Cancer Res; 1997 Mar 01; 3(3):409-17. PubMed ID: 9815699
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients.
    Kurzrock R, Rosenblum MG, Sherwin SA, Rios A, Talpaz M, Quesada JR, Gutterman JU.
    Cancer Res; 1985 Jun 01; 45(6):2866-72. PubMed ID: 3921249
    [Abstract] [Full Text] [Related]

  • 12. [Phase I-II study of recombinant interferon gamma].
    Adachi K, Ogawa M, Usui N, Inagaki J, Horikoshi N, Inoue K, Nakada H, Tada A, Yamazaki H, Mukaiyama T.
    Gan To Kagaku Ryoho; 1985 Jun 01; 12(6):1331-8. PubMed ID: 2988459
    [Abstract] [Full Text] [Related]

  • 13. Phase II study of recombinant human interferon-gamma in metastatic renal cell carcinoma.
    Bruntsch U, de Mulder PH, ten Bokkel Huinink WW, Clavel M, Drozd A, Kaye SB, Renard J, van Glabbeke M.
    J Biol Response Mod; 1990 Jun 01; 9(3):335-8. PubMed ID: 2116500
    [Abstract] [Full Text] [Related]

  • 14. Paclitaxel administered by a 1-hour infusion: A phase I-II trial comparing two schedules.
    Hainsworth JD, Raefsky EL, Greco FA.
    Cancer J Sci Am; 1995 Jun 01; 1(4):281-7. PubMed ID: 9166489
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Phase I evaluation of therapy with four schedules of 5-fluorouracil by continuous infusion combined with recombinant interferon alpha.
    Greenblatt MS, Mangalik A, Ferguson J, Elias L.
    Clin Cancer Res; 1995 Jun 01; 1(6):615-20. PubMed ID: 9816023
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, Nash M, Levy L, Atkinson EN, Zhang HZ, Melichar B, Patenia R, Templin S, Scott W, Platsoucas CD.
    Clin Cancer Res; 2000 Jun 01; 6(6):2268-78. PubMed ID: 10873077
    [Abstract] [Full Text] [Related]

  • 20. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD, Greco FA.
    Semin Oncol; 1995 Dec 01; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.